Stockscreener 앱 받기
23.55
1.73%
0.415
전일 마감가:
$23.13
열려 있는:
$23.58
하루 거래량:
334.65K
Relative Volume:
0.07
시가총액:
$11.71B
수익:
$4.72B
순이익/손실:
$-232.00M
주가수익비율:
-50.49
EPS:
-0.4663
순현금흐름:
$284.00M
1주 성능:
-3.72%
1개월 성능:
-10.87%
6개월 성능:
+16.83%
1년 성능:
+126.03%
1일 변동 폭
$23.33
$23.60
1주일 범위
$22.74
$25.68
52주 변동 폭
$8.02
$27.72
엘란코 Stock (ELAN) Company Profile
명칭
Elanco Animal Health Inc
전화
877-352-6261
주소
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, ZTS, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
23.55 | 11.50B | 4.72B | -232.00M | 284.00M | -0.4663 |
TAK
Takeda Pharmaceutical Co Adr
|
18.21 | 56.58B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
114.42 | 47.85B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.94 | 43.75B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.73 | 33.47B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
585.10 | 22.91B | 3.18B | 1.33B | 1.04B | 27.90 |
엘란코 Stock (ELAN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-22 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-11-21 | 개시 | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | 업그레이드 | Argus | Hold → Buy |
| 2025-10-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-07-17 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | 개시 | UBS | Buy |
| 2024-12-02 | 개시 | Leerink Partners | Market Perform |
| 2024-09-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-19 | 개시 | Jefferies | Buy |
| 2023-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-04-20 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-08-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-07-21 | 다운그레이드 | Goldman | Buy → Sell |
| 2022-07-12 | 개시 | Piper Sandler | Neutral |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-10-28 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-06-15 | 업그레이드 | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2021-05-11 | 업그레이드 | Gabelli & Co | Hold → Buy |
| 2021-04-15 | 개시 | Stifel | Buy |
| 2021-03-22 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2021-02-26 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | 다운그레이드 | Argus | Buy → Hold |
| 2020-11-09 | 다운그레이드 | Barclays | Overweight → Underweight |
| 2020-08-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | 재개 | Credit Suisse | Neutral |
| 2020-08-04 | 재개 | Goldman | Buy |
| 2020-07-27 | 다운그레이드 | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-12-19 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | 개시 | Barclays | Overweight |
| 2019-08-26 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | 업그레이드 | UBS | Sell → Neutral |
| 2019-05-23 | 개시 | Guggenheim | Neutral |
| 2019-03-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | 재개 | Morgan Stanley | Equal-Weight |
| 2019-02-12 | 개시 | William Blair | Mkt Perform |
| 2019-01-23 | 개시 | UBS | Sell |
| 2019-01-15 | 개시 | Argus | Buy |
| 2018-10-15 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
엘란코 주식(ELAN)의 최신 뉴스
Decoquinate Market Is Going to Boom Rapidly With Top Key Players - openPR.com
Companion Animal Health Market Forecast 2026-2033 Featuring Strategic Analysis of Agrolabo, Boehringer Ingelheim, Ceva, Elanco, IDEXX Labs and More - Yahoo Finance Singapore
Elanco Animal Health Inc (ELAN) Shares Gap Down to $23.21 on Mar 27 - GuruFocus
Elanco Beats Investor Suit Over Dog Drug's Reg Challenges - Law360
Elanco Animal Health Drops More Than 5% – What’s Behind the Abrupt Decline? - Bitget
Vanguard reports 0 shares of Elanco after realignment (NYSE: ELAN) - Stock Titan
Elanco Gets Investors’ Dog Itch Drug Development Suit Dismissed - Bloomberg Law News
Elanco (ELAN) Jumps 19.7% to Record High on Earnings Boost - MSN
Syngulon announces licensing agreement with Elanco Animal Health - PRWeb
Elanco (ELAN) CEO receives deferred stock units in compensation grant - Stock Titan
Elanco (NYSE: ELAN) executive receives new deferred stock unit grant - Stock Titan
Elanco (ELAN) CFO receives 8.216 deferred stock units as compensation award - Stock Titan
Elanco Animal (ELAN) climbs 7.6% on upbeat outlook, sets sights on AI - MSN
ELAN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Pricier vet care: Fewer visits but still many $11,000 surgeries - fortune.com
JPMorgan Chase & Co. Has $38.64 Million Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
New Mexico Educational Retirement Board Invests $2 Million in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Inc (ELAN) Shares Down 3.01% on Mar 20 - GuruFocus
ELAN Stock Price, Quote & Chart | ELANCO ANIMAL HEALTH INC (NYSE:ELAN) - ChartMill
Where is Elanco Animal Health Incorporated (ELAN) headed according to the Street? - MSN
ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board - The Manila Times
Former Elanco director joins ImmuCell board in calf-health push - Stock Titan
Animal Health Market size to reach $199.1 Billion by 2035 | Key - openPR.com
Elanco Animal Health (ELAN) Surges 7.6%: Is This an Indication of Further Gains? - Yahoo Finance
Elanco Animal (ELAN) Climbs 7.6% on Upbeat Outlook, Sets Sights on AI - Insider Monkey
Chipmakers Recap: What is the next catalyst for Elanco Animal Health IncorporatedRecession Risk & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
Elanco jumps as investors focus on upbeat 2026 outlook after strong Q4 results - Quiver Quantitative
Elanco Animal Health (NYSE:ELAN) Shares Up 7.1%Here's What Happened - MarketBeat
Elanco Animal Health Incorporated $ELAN Holdings Cut by Holocene Advisors LP - MarketBeat
CSM Advisors LLC Takes Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Cinctive Capital Management LP Reduces Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Short Interest Down 18.1% in February - MarketBeat
Volatility Watch: Will Elanco Animal Health Incorporated stock recover after earnings2026 Levels & Growth Focused Stock Reports - baoquankhu1.vn
Private Management Group Inc. Cuts Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Incorporated $ELAN Shares Bought by Perbak Capital Partners LLP - MarketBeat
Integral Health Asset Management LLC Grows Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Dodge & Cox Sells 135,395 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Van ECK Associates Corp Cuts Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
Landscape Capital Management L.L.C. Purchases 155,048 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Global Animal Parasiticides Market Size, Growth, Trends & Forecast to 2033 Merck, Virbac, Zoetis*, Elanco - openPR.com
Elanco Animal Health Incorporated $ELAN Shares Bought by Capital World Investors - MarketBeat
Elanco Animal Health Incorporated $ELAN Position Lessened by First Trust Advisors LP - MarketBeat
Elanco Stock Analysis: Strong Gains Mask Revenue, Margin Concerns | 2026News and Statistics - IndexBox
Barrow Hanley Mewhinney & Strauss LLC Sells 2,592,747 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
UBS maintains Buy on ELAN (Elanco Animal Health Incorporated) March 2026 - Meyka
Elanco (ELAN) executive receives grant of 1,360 deferred stock units - Stock Titan
Elanco (ELAN) CEO Jeffrey Simmons receives 4,497 deferred stock units grant - Stock Titan
Elanco (NYSE: ELAN) CFO receives deferred stock unit award - Stock Titan
Elanco (NYSE: ELAN) officer receives new deferred stock unit grant - Stock Titan
Elanco Animal Health stock reaffirmed at Buy by UBS on innovation momentum - Investing.com Canada
엘란코 (ELAN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.30%
0.39%
자본화:
|
볼륨(24시간):